Static Chart J. Molner

Equities

Delayed Nasdaq Tallinn Other stock markets 07:00:00 12/07/2024 pm IST			5-day change	1st Jan Change
15.3 ^EUR	-3.16%		+2.68%	+11.27%

30/04	J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	CI
04/03	J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	CI

Duration

Period